TürkiyeSGK and reimbursement
SGK to add a drug used in cystic fibrosis treatment to reimbursement
A statement by a ministry, institution or international organisation, or a change in regulations. It is not evidence about how well a treatment works.
SGK (Social Security Institution) announced that it will add a drug used to treat cystic fibrosis to the reimbursement list. Five cancer immunotherapy drugs will also be added to the list. About 1,000 people with cystic fibrosis are expected to benefit from the regulation.
What does it mean for patients and families?
A health board report is needed to access the drug. People with cystic fibrosis can find out the report requirements from the center that follows them.
Source
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Cystic fibrosis
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.